EVolution Therapeutics is a preclinical stage biotechnology company, spun out of Aston University. EV-based therapeutics represent a next generation of treatment for intractable diseases and we look to pioneer the development of this platform to modulate the innate immune response for treatment of inflammatory diseases. At EVolution Therapeutics we have assembled a multidisciplinary team who are passionate about translational science, along with a vast expertise in EVs and immunology.